,,ii  #aagth ,,congress  #ast ,session  
,s4 #cagd  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,november #d1  
#bjba,mr4 ,rubio 7for himself and ,ms4  
,warren7 introduced the following bill2 
which was read twice and referred to the
 ,committee on ,armed ,services  ,a     
,,bill  ,to implement the               
recommendations of the ,inspector       
,general of the ,department of ,defense 
with respect to mitigation of foreign   
suppliers in the pharmaceutical supply  
chain of the ,department of ,defense4   
#a4 ,short title ,this ,act may be cited
 as the ,strengthening ,supply ,chains  
for ,servicemembers and ,security ,act4 
#b4 ,risk management for ,department of 
,defense supply chains  7a7 ,risk       
management for all ,department of       
,defense supply chains ,not later than  
#ahj days after the date of the         
enactment of this ,act1 the ,under      
,secretary of ,defense for ,acquisition 
and ,sustainment shall-- 7#a7 develop   
and issue implementing guidance for risk

 management for ,department of ,defense 
supply chains for materiel for the      
,department1 including pharmaceuticals2 
7#b7 identify1 in coordination with the 
,commissioner of ,food and ,drugs1      
supply chain information gaps regarding 
reliance on foreign suppliers of drugs1 
including active pharmaceutical         
ingredients and final drug products2 and
  7#c7 submit to ,congress a report     
regarding-- 7,a7 existing information   
streams1 if any1 that may be used to    
assess the reliance by the ,department  
of ,defense on high-risk foreign        
suppliers of drugs2  7,b7               
vulnerabilities in the drug supply      
chains of the ,department of ,defense2  
and  7,c7 any recommendations to        
address-- 7i7 information gaps          
identified under paragraph 7#b72 and    
7ii7 any risks related to such reliance 
on foreign suppliers4  7b7 ,risk        
management for ,department of ,defense  
pharmaceutical supply chain ,the        
,director of the ,defense ,health       

,agency shall-- 7#a7 not later than one 
year after the issuance of the guidance 
required by subsection 7a77#a71 develop 
and publish implementing guidance for   
risk management for the ,department of  
,defense supply chain for               
pharmaceuticals2 and  7#b7 establish a  
working group-- 7,a7 to assess risks to 
the pharmaceutical supply chain2  7,b7  
to identify the pharmaceuticals most    
critical to beneficiary care at military
 treatment facilities2 and  7,c7 to     
establish policies for allocating scarce
 pharmaceutical resources in case of a  
supply disruption4  7c7 ,responsiveness 
testing of ,defense ,logistics ,agency  
pharmaceutical contracts ,the ,director 
of the ,defense ,logistics ,agency shall
 modify ,defense ,logistics ,agency     
,instructions #ejbe4jc and #caaj4ja--   
7#a7 to require ,defense ,logistics     
,agency ,troop ,support to coordinate   
annually with customers in the military 
departments to conduct responsiveness   
testing of the ,defense ,logistics      

,agency's contingency contracts for     
pharmaceuticals2 and  7#b7 to include   
the results of that testing1 as reported
 by customers in the military           
departments1 in the annual reports of   
the ,warstopper ,program4